eudragit-e has been researched along with mobic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Date, AA; Khachane, P; Nagarsenker, MS | 1 |
Cao, T; Haser, A; Lubach, JW; Zhang, F | 1 |
2 other study(ies) available for eudragit-e and mobic
Article | Year |
---|---|
Eudragit EPO nanoparticles: application in improving therapeutic efficacy and reducing ulcerogenicity of meloxicam on oral administration.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Male; Meloxicam; Microscopy, Electron, Transmission; Nanocapsules; Nanotechnology; Particle Size; Polymethacrylic Acids; Rats; Rats, Sprague-Dawley; Solubility; Stomach Ulcer; Thiazines; Thiazoles | 2011 |
In Situ Salt Formation during Melt Extrusion for Improved Chemical Stability and Dissolution Performance of a Meloxicam-Copovidone Amorphous Solid Dispersion.
Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Drug Storage; Excipients; Freezing; Hot Temperature; Meglumine; Meloxicam; Polymethacrylic Acids; Pyrrolidines; Vinyl Compounds; X-Ray Diffraction | 2018 |